TREATMENT OF PATIENTS WITH NEWLY DIAGNOSED MEDULLOBLASTOMA, SUPRATENTORIAL PRIMITIVE NEUROECTODERMAL TUMOR, OR ATYPICAL TERA TOID RHABDOID TUMOR – SJMB03
Amendment 2.0, September 8, 2005, Resubmitted May 31, 2006
A Study of Unilateral Retinoblastoma With and Without Histopathologic High-Risk Features and the Role of Adjuvant Chemotherapy
9:45
אין תגובות
ARET0332
A Groupwide Phase III Study
STUDY CHAIR: Murali Chintagumpala, M.D.
